Money & Corp · Court of Appeals for the D.C. Circuit
Aug 18, 2026
AI illustrationServier Pharmaceuticals claims it should qualify for drug pricing discounts. Is that fair?
Your callDid the make the right call on Servier's discount request?
TL;DR
- 1Servier Pharmaceuticals acquired the drug Tibsovo from a previous manufacturer and wanted to qualify for .
- 2The said Servier didn't sell any Tibsovo under Medicare in 2021, so it doesn’t qualify for phase-in discounts.
- 3Servier argued that previous sales should count and sued for the right to phase in its obligations for discounts.




